With recent severe restrictions to abortion accessibility in the United States and a pending
Supreme Court case challenging the Food and Drug Administration's approval of …

Mifepristone approval by the United States (US) Food and Drug Administration in 2000
revolutionized abortion care in this country. In 2020, 53% of people having facility-based …

Objectives Recent lawsuits have challenged FDA approval and the continued availability of
the medication mifepristone for abortion care in the US. Whatever the outcome of these …

Introduction Although prior research has shown that misoprostol is more effective for
medication abortion when used with mifepristone rather than as a single agent, mifepristone …

Objectives This study aimed to understand individual experiences with medication abortion
using misoprostol-only among people living in the United States. Study design We …

Background In February 2011, an Ohio law took effect mandating use of the United States
Food and Drug Administration (FDA)-approved protocol for mifepristone, which is used with …

Given the highly political nature of abortion in the United States, the provision of medical
abortion with mifepristone (Mifeprex®) and misoprostol has always occurred under a unique …

Ngoc et al.[1], in their double-blind randomized placebocontrolled trial, show that
mifepristone+ misoprostol is more efficacious than misoprostol-only for early medical …

BACKGROUND: Nonsurgical abortion methods have the potential to improve access to high-
quality abortion care. Until recently, availability and utilization of mifepristone medical …

Recommendations for the use of mifepristone and misoprostol for inducing abortion and for
managing incomplete abortion are contained within the 2012 WHO guideline Safe abortion …